Bone and metabolism: A complex crosstalk

Hormone Research

Volumn 71, Issue SUPPL. 1, 2009, Pages 134-138

  Lieben, Liesbet ^a   Callewaert, Filip ^a   Bouillon, Roger ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Bone remodeling; Leptin; OST PTP; Osteocalcin; Sympathetic nervous system

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; GLUCOSE; LEPTIN; NEUROMEDIN U; NEUROPEPTIDE Y; OSTEOCALCIN; PEPTIDE YY; PROTEIN TYROSINE PHOSPHATASE;

ADIPOCYTE; ADRENERGIC SYSTEM; BODY FAT; BONE METABOLISM; BONE REMODELING; CONFERENCE PAPER; ENDOCRINE FUNCTION; ENERGY METABOLISM; GLUCOSE METABOLISM; HOMEOSTASIS; HORMONAL REGULATION; HUMAN; METABOLISM; MOLECULAR INTERACTION; NERVE TRACT; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; REGULATORY MECHANISM; SKELETON;

ANIMALS; BONE AND BONES; BONE REMODELING; CENTRAL NERVOUS SYSTEM; ENERGY METABOLISM; HOMEOSTASIS; HUMANS; METABOLIC NETWORKS AND PATHWAYS; METABOLISM; MODELS, BIOLOGICAL;

EID: 58549099858     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000178056     Document Type: Conference Paper

References (22)

1. Bouillon R: Diabetic bone disease. Calcif Tissue Int 1991;49:155-160.
2. Strotmeyer ES, Cauley JA: Diabetes mellitus, bone mineral density, and fracture risk. Curr Opin Endocrinol Diabetes Obes 2007;14:429-435.
3. Van den Berghe G, Van Roosbroeck D, Vanhove P, Wouters PJ, De Pourcq L, Bouillon R: Bone turnover in prolonged critical illness: effect of vitamin D. J Clin Endocrinol Metab 2003;88:4623-4632.
4. Bouillon R, Bischoff-Ferrari H, Willett W: Vitamin D and health: perspectives from mice and man. J Bone Miner Res 2008;23:974-979.
5. Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, Dacquin R, Mee PJ, McKee MD, Jung DY, Zhang Z, Kim JK, Mauvais-Jarvis F, Ducy P, Karsenty G: Endocrine regulation of energy metabolism by the skeleton. Cell 2007;130:456-469.
6. Karsenty G: Convergence between bone and energy homeostases: leptin regulation of bone mass. Cell Metab 2006;4:341-348.
7. Elefteriou F: Regulation of bone remodeling by the central and peripheral nervous system. Arch Biochem Biophys 2008;473:231-236.
8. Coll AP, Farooqi IS, O'Rahilly S: The hormonal control of food intake. Cell 2007;129:251-262.
9. Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, Shen J, Vinson C, Rueger JM, Karsenty G: Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 2000;100:197-207.
10. Takeda S, Elefteriou F, Levasseur R, Liu X, Zhao L, Parker KL, Armstrong D, Ducy P, Karsenty G: Leptin regulates bone formation via the sympathetic nervous system. Cell 2002;111:305-317.
11. Elefteriou F, Ahn JD, Takeda S, Starbuck M, Yang X, Liu X, Kondo H, Richards WG, Bannon TW, Noda M, Clement K, Vaisse C, Karsenty G: Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 2005;434:514-520.
12. Fu L, Patel MS, Bradley A, Wagner EF, Karsenty G: The molecular clock mediates leptin-regulated bone formation. Cell 2005;122:803-815.
13. Ahn JD, Dubern B, Lubrano-Berthelier C, Clement K, Karsenty G: Cart overexpression is the only identifiable cause of high bone mass in melanocortin 4 receptor deficiency. Endocrinology 2006;147:3196-3202.
14. Baldock PA, Sainsbury A, Couzens M, Enriquez RF, Thomas GP, Gardiner EM, Herzog H: Hypothalamic Y2 receptors regulate bone formation. J Clin Invest 2002;109:915-921.
15. Sato S, Hanada R, Kimura A, Abe T, Matsumoto T, Iwasaki M, Inose H, Ida T, Mieda M, Takeuchi Y, Fukumoto S, Fujita T, Kato S, Kangawa K, Kojima M, Shinomiya K, Takeda S: Central control of bone remodeling by neuromedin U. Nat Med 2007;13:1234-1240.
16. Farooqi IS, Yeo GS, Keogh JM, Aminian S, Jebb SA, Butler G, Cheetham T, O'Rahilly S: Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. J Clin Invest 2000;106:271-279.
17. Guerardel A, Tanko LB, Boutin P, Christiansen C, Froguel P: Obesity susceptibility CART gene polymorphism contributes to bone remodeling in postmenopausal women. Osteoporos Int 2006;17:156-157.
18. Kurvers HA: Reflex sympathetic dystrophy: facts and hypotheses. Vasc Med 1998;3:207-214.
19. Weinreb M, Shinar D, Rodan GA: Different pattern of alkaline phosphatase, osteopontin, and osteocalcin expression in developing rat bone visualized by in situ hybridization. J Bone Miner Res 1990;5:831-842.
20. Ducy P, Desbois C, Boyce B, Pinero G, Story B, Dunstan C, Smith E, Bonadio J, Goldstein S, Gundberg C, Bradley A, Karsenty G: Increased bone formation in osteocalcin-deficient mice. Nature 1996;382:448-452.
21. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T: The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001;7:941-946.
22. Mauro LJ, Olmsted EA, Skrobacz BM, Mourey RJ, Davis AR, Dixon JE: Identification of a hormonally regulated protein tyrosine phosphatase associated with bone and testicular differentiation. J Biol Chem 1994;269:30659-30667.